EGFR and cancer: To model EGFR variant functionality, we employed the PC9 cell line, as it is EGFR-dependent, sensitive to all generations of EGFR TKIs, and amenable to high-throughput genetic screening, while also providing the complexity associated with naturally occurring passenger mutations in cancer.